Results per Page:
RR tracks: a new way to measure viral transmission
From the Bedford Lab, Vaccine and Infectious Disease, Public Health and Human Biology Divisions
COVID watchdawgs: SARS-CoV-2 at UW in the pandemic’s early days
From the Chu and Weil Labs, UW Medicine, in collaboration with the Cancer Basic Biology Program of the Cancer Consortium and Fred Hutch Vaccine and Infectious Disease Division
The impact of antibodies to other coronaviruses on risk of SARS-CoV-2 infection in mothers and infants
From the Lehman and Overbaugh Labs, Human Biology Division
COVID-19 complacency: ‘A hard shift for the immunocompromised’
Even with vaccines and antivirals, cancer patients and many others are still vulnerable to infection; some safety tips for this evolving pandemic
Do viruses have heads, shoulders, knees, and toes?
From the Stamatatos, Pancera and McGuire labs, Vaccine and Infectious Disease Division
Coronavirus evolution resembles an intersecting network of branches
From the Bedford lab, Vaccine and Infectious Disease Division
Cancer, COVID-19 and proceeding with caution
Patients in treatment and those with compromised or suppressed immune systems eye the future — and pandemic’s wane — warily
Catching up with cancer as COVID-19 starts to ebb
Public health researchers scramble to get preventive cancer screenings back on peoples’ radar – and calendars – as cases dwindle and restrictions lift
College students muster for big COVID-19 vaccine study
12,000 participants sought in study to prove if vaccine can block asymptomatic transmission
Learning to trust science with your life
Diseases like cancer and COVID-19 can be scary; leaning into the science helps you feel more empowered
Shed the pandemic pounds ... and the stupor
As vaccines roll out and the crisis ebbs, get more sleep, eat mostly plants, keep moving and stay connected
Cancer patients and the COVID-19 vaccines
Clinicians, cancer patients and coronavirus researchers weigh in on vaccination safety, timing, allergy concerns and more
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer
Celebrate safely: Scientists offer advice, urge vigilance during holidays
'Now is the time for delayed gratification' — so skip big gatherings and travel to prevent the spread of COVID-19
'Everything we’ve been training for is happening now'
How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Public health’s pandemic pivot
With disease modeling, virtual events and a renewed focus on antiracism, Fred Hutch population scientists adapt their work to COVID-19
What happens if the coronavirus’s spikes mutate?
First-of-its-kind study explores how changes in the virus’s ‘lock picks’ could help or hinder its ability to sneak into our cells
Riding out the pandemic with Obliteride
Annual fundraiser goes DIY with creative workouts, global participation and Glow Orange week
The latest on how COVID-19 affects cancer patients
Hutch researchers share new data on mortality rates and racial disparities in treatment; launch statewide COVID-19 and cancer data repository
Fred Hutch joins international COVID-19 vaccine effort
New clinical trials network will evaluate vaccines and antibodies to prevent COVID-19